Boston Scientific

Profile narrative

Boston Scientific develops, manufactures and markets a broad portfolio of medical devices used in interventional medical specialties. Its product lines include cardiology, endoscopy, urology, neuromodulation and chronic pain management solutions. The company supplies hospitals, ambulatory surgery centers and physicians worldwide, focusing on minimally invasive technologies that improve patient outcomes. Its offerings are designed to diagnose, treat and manage a variety of cardiovascular, gastrointestinal and neurological conditions.

Boston Scientific is headquartered in Marlborough, Massachusetts, United States of America, and maintains a global operational footprint with facilities and sales offices in numerous countries. The organization employs tens of thousands of staff across research and development, manufacturing, commercial and support functions. Its products are distributed to healthcare providers in North America, Europe, Asia‑Pacific and other regions, serving a diverse international market.

The firm is distinguished by its specialization in minimally invasive and implantable devices, positioning it as a key player in the medical device industry. It operates under stringent regulatory oversight from the U.S. Food and Drug Administration and comparable health authorities worldwide, ensuring compliance with safety and efficacy standards. Boston Scientific is a publicly traded corporation listed on the New York Stock Exchange under the ticker BSX, with ownership dispersed among institutional and individual shareholders. The company functions as an independent entity, not a subsidiary of another corporation, and has pursued strategic acquisitions to expand its technological capabilities. Its sustained investment in research and development underpins a reputation for innovation in fields such as drug‑eluting stents, endoscopic therapies and neurostimulation systems.

Incidents

2 incidents linked to this organisation.